SPG21 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.266200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.762600E-01
Normal-vs-Stage2
2.718400E-01
Normal-vs-Stage3
2.927600E-01
Normal-vs-Stage4
2.563200E-01
Stage1-vs-Stage2
4.042800E-01
Stage1-vs-Stage3
2.860600E-01
Stage1-vs-Stage4
3.789000E-01
Stage2-vs-Stage3
3.933800E-01
Stage2-vs-Stage4
8.118200E-01
Stage3-vs-Stage4
6.588600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.167800E-01
Normal-vs-AfricanAmerican
4.911000E-01
Normal-vs-Asian
4.595400E-01
Caucasian-vs-AfricanAmerican
5.846600E-01
Caucasian-vs-Asian
6.343200E-01
AfricanAmerican-vs-Asian
8.911000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.198000E-01
Normal-vs-Female
2.576200E-01
Male-vs-Female
6.462600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.508200E-01
Normal-vs-Age(41-60Yrs)
3.713000E-01
Normal-vs-Age(61-80Yrs)
1.453840E-01
Normal-vs-Age(81-100Yrs)
7.070800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.162800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.910600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.345800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.540200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.621800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.140200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.118800E-01
Normal-vs-Daily Drinker
2.649800E-01
Normal-vs-Weekly Drinker
4.123200E-01
Normal-vs-Occasional Drinker
1.723160E-01
Normal-vs-Social Drinker
9.761900E-02
Non Drinker-vs-Daily Drinker
6.972400E-01
Non Drinker-vs-Weekly Drinker
9.144600E-01
Non Drinker-vs-Occasional Drinker
9.422600E-01
Non Drinker-vs-Social Drinker
5.415200E-01
Daily Drinker-vs-Weekly Drinker
6.868200E-01
Daily Drinker-vs-Occasional Drinker
7.484200E-01
Daily Drinker-vs-Social Drinker
8.367600E-01
Weekly Drinker-vs-Occasional Drinker
8.624800E-01
Weekly Drinker-vs-Social Drinker
5.345800E-01
Occasional Drinker-vs-Social Drinker
5.180400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.720600E-01
Normal-vs-Grade 2
9.706800E-01
Normal-vs-Grade 3
9.886200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.17240000002883E-06
Grade 1-vs-Grade 3
1.160350E-03
Grade 1-vs-Grade 4
8.720600E-01
Grade 2-vs-Grade 3
5.388400E-01
Grade 2-vs-Grade 4
9.706800E-01
Grade 3-vs-Grade 4
9.886200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.069420E-01
Normal-vs-NonDiabetic
2.603600E-01
Diabetic-vs-NonDiabetic
2.170600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.571200E-01
Normal-vs-NoPancreatitis
2.057600E-01
Pancreatitis-vs-NoPancreatitis
5.668200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.206180E-01
Normal-vs-N1
3.022000E-01
N0-vs-N1
3.114600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.881200E-01
Normal-vs-TP53-NonMutant
4.901700E-02
TP53-Mutant-vs-TP53-NonMutant
3.404400E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
